Search research articles
Contact Us
Filters
Showing results (61-70 of 87) with videos related to
Page
of 9
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 14, 2015
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor-Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study
Anthony Mills, Gordon Crofoot, Cheryl McDonald, et al.
AIDS (London, England)
|
June 1, 2018
Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ : CD8+ ratio
Rachael A Hughes, Margaret T May, Kate Tilling, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 6, 2013
Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy
Elizabeth L Yanik, Sonia Napravnik, Stephen R Cole, et al.
Eclinicalmedicine
|
September 26, 2022
Associations between female birth sex and risk of chronic kidney disease development among people with HIV in the USA: A longitudinal, multicentre, cohort study
Brittany A Shelton, Deirdre Sawinski, Paul A MacLennan, et al.
Antiviral Therapy
|
February 7, 2009
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies
Ross J Harris, Jonathan A C Sterne, Sophie Abgrall, et al.
The Journal of Infectious Diseases
|
February 16, 2010
Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection
David A Cooper, Jayvant Heera, James Goodrich, et al.
Drug and Alcohol Dependence
|
November 4, 2022
Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United States
Po-Hung Chen, Karine Yenokyan, Anthony T Fojo, et al.
The New England Journal of Medicine
|
October 4, 2008
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection
Gerd Fätkenheuer, Mark Nelson, Adriano Lazzarin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 20, 2014
Enhanced personal contact with HIV patients improves retention in primary care: a randomized trial in 6 US HIV clinics
Lytt I Gardner, Thomas P Giordano, Gary Marks, et al.
HIV Clinical Trials
|
October 30, 2003
A multi-investigator/institutional DNA bank for AIDS-related human genetic studies: AACTG Protocol A5128
David W Haas, Grant R Wilkinson, Daniel R Kuritzkes, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 87) with videos related to
Sort By:
Page
of 9
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 14, 2015
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor-Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study
Anthony Mills, Gordon Crofoot, Cheryl McDonald, et al.
AIDS (London, England)
|
June 1, 2018
Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ : CD8+ ratio
Rachael A Hughes, Margaret T May, Kate Tilling, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 6, 2013
Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy
Elizabeth L Yanik, Sonia Napravnik, Stephen R Cole, et al.
Eclinicalmedicine
|
September 26, 2022
Associations between female birth sex and risk of chronic kidney disease development among people with HIV in the USA: A longitudinal, multicentre, cohort study
Brittany A Shelton, Deirdre Sawinski, Paul A MacLennan, et al.
Antiviral Therapy
|
February 7, 2009
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies
Ross J Harris, Jonathan A C Sterne, Sophie Abgrall, et al.
The Journal of Infectious Diseases
|
February 16, 2010
Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection
David A Cooper, Jayvant Heera, James Goodrich, et al.
Drug and Alcohol Dependence
|
November 4, 2022
Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United States
Po-Hung Chen, Karine Yenokyan, Anthony T Fojo, et al.
The New England Journal of Medicine
|
October 4, 2008
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection
Gerd Fätkenheuer, Mark Nelson, Adriano Lazzarin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 20, 2014
Enhanced personal contact with HIV patients improves retention in primary care: a randomized trial in 6 US HIV clinics
Lytt I Gardner, Thomas P Giordano, Gary Marks, et al.
HIV Clinical Trials
|
October 30, 2003
A multi-investigator/institutional DNA bank for AIDS-related human genetic studies: AACTG Protocol A5128
David W Haas, Grant R Wilkinson, Daniel R Kuritzkes, et al.
Page
of 9